S
Sino Biopharmaceutical
Sustainability Report and Carbon Intensity Rankings
Is Sino Biopharmaceutical doing their part?
Their DitchCarbon score is 54
Sino Biopharmaceutical has a DitchCarbon Score of 54, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, which is a measure of the greenhouse gases emitted relative to the value they generate. A score of 54 suggests there is room for improvement in reducing carbon intensity and enhancing their environmental performance.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Sino Biopharmaceutical operates in the industrial manufacturing sector, which has a very low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
Sino Biopharmaceutical, located in Western Australia, operates in a region with an unknown carbon intensity rating. This uncertainty makes it challenging to assess the direct impact of the country’s energy mix on the company’s sustainability efforts.
Unlock 30+ emissions data points on Sino Biopharmaceutical
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Sino Biopharmaceutical
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
12.71%
...this company is doing 12.71% better in emissions than the industry average.
Sino Biopharmaceutical Limited, founded in 2000, is situated on Hong Kong Island at 1 Harbour Road, Hong Kong. Operating within the pharmaceuticals industry, the company specializes in the development and manufacturing of medical products. It is a key player in the Asian pharmaceutical market, offering innovative healthcare solutions.
emission intelligence's platform recommendations for Sino Biopharmaceutical
Sino Biopharmaceutical should explore opportunities for fuel switching in transportation and operations to potentially reduce their emissions by 15%.
Bad news, Sino Biopharmaceutical hasn't committed to SBTi goals yet.
Sino Biopharmaceutical has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is either in the process of setting or has not publicly disclosed its goals for reducing greenhouse gas emissions in line with climate science.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.